Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Exact Sciences Trading Volume Surges 146.53% to $233 Million Ranking 428th in Daily Turnover

Market BriefThursday, May 1, 2025 8:01 pm ET

1min read

On May 1, 2025, exact sciences (EXAS) saw a significant surge in trading volume, with a turnover of $233 million, marking a 146.53% increase from the previous day. This placed the company at the 428th position in terms of trading volume for the day. The stock price of Exact Sciences also rose by 3.33%, marking the second consecutive day of gains, with a total increase of 5.29% over the past two days.

Exact Sciences reported its first-quarter 2025 financial results, highlighting a total revenue of $707 million, reflecting an 11% increase on both a reported and core revenue basis. The screening revenue specifically rose by 14% to $540 million, while the precision oncology revenue increased by 2% to $167 million during the quarter.

During the earnings call, Exact Sciences emphasized its robust revenue growth, maintaining a strong 26% revenue compound annual growth rate (CAGR). The company's adjusted net loss for the quarter was $0.21 per diluted share, narrowing from a loss of $0.37 per share in the same period last year.

Exact Sciences also provided updated guidance for the full year 2025, projecting revenue to range between $3.07 billion and $3.12 billion. This guidance reflects the company's confidence in its continued growth and market position.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.